NCT06797648View on ClinicalTrials.gov

Epidemiology of Infection in Acute Myeloid Leukemia (AML)

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2029

Conditions
Acute Myeloid Leukemia
Interventions
OTHER

data analysis

follow up after 15 months

Trial Locations (1)

00168

Fondazione Policlinico Universitario A. Gemelli Irccs, Uoc Ematologia, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT06797648 - Epidemiology of Infection in Acute Myeloid Leukemia (AML) | Biotech Hunter | Biotech Hunter